Attenuation of β-amyloid-induced neuroinflammation by KHG21834 in vivo

키워드

참고문헌 (41)

1. Breitner, J. C., "The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease", Annu. Rev. Med., 47, pp.401~411 (1996)
2. Eikelenboom, P., "Neuroinflammatory perspectives on the two faces of Alzheimer's disease", J. Neural. Transm., 111, pp.281~294 (2004)
3. Raine, C. S., "Multiple sclerosis: immune system molecule expression in the central nervous system", J. Neuropathol. Exp. Neurol., 53, pp.328~337 (1994)
4. Matyszak, M. K., "Inflammation in the CNS: balance between immunological privilege and immune responses", Prog. Neurobiol., 56, pp.19~35 (1998)
5. Giulian, D., "Microglia and the immune pathology of Alzheimer disease", Am. J. Hum. Genet., 65, pp.13~18 (1999)
6. Gonzalez-Scarano, F., "Microglia as mediators of infammatory and degenerative diseases", Annu. Rev. Neurosci., 22, pp.219~240 (1999)
7. Qin, L., "Microglia enhance β-amyloid peptide- induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species", J. Neurochem., 83, pp.973~983 (2002)
8. Combs, C. K., "β-amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis", J. Neurosci., 21, pp.1179~1188 (2001)
9. Gao, H. M., "Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease", J. Neurochem., 81, pp.1285~1297 (2002)
10. Liu, Y., "Inhibition by Naloxone stereoisomers of β-amyloid peptide (1-42) induced superoxide production in microglia and degeneration of cortical and mesencephalic neurons", J. Pharmacol. Exp. Ther., 302, pp.1212~1219 (2002)
11. Knethen, A., "NO-evoked macrophage apoptosis is attenuated by cAMP-induced gene expression", Mol. Med., 5, pp.672~684 (1999)
12. Heneka, M. T., "Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha", lipopolysaccharide, 1998, pp.71, 88~94
13. Korhonen, R., "Nitric oxide production and signalling in inflammation", Curr. Drug Targets Inflamm. Allergy, 4, pp.471~479 (2005)
14. Kleinert, H., "Regulation of the expression of inducible nitric oxide synthase", Biol. Chem., 384, pp.1343~1364 (2003)
15. Bhat, N. R., "Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulated primary glial cultures", J. Neurosci., 18, pp.1633~1641 (1998)
16. Ajizian, S. J., "Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma", J. Infect. Dis., 179, pp.939~944 (1999)
17. Carter, A. B., "Both Erk and p38 Kinases are necessary for cytokine gene transcription", Am. J. Respir. Cell. Mol. Biol., 20, pp.751~758 (1999)
18. Moore, A. H., "Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease", Adv. Drug Deliv. Rev., 54, pp.1627~1656 (2002)
19. Wang, M. J., "Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation", Eur. J. Neurosci., 16, pp.2103~2112 (2002)
20. Allan, S. M., "Interleukin-1β and neuronal injury", Nat. Rev. Immunol., 5, pp.629~640 (2005)
21. Emsley, H. C. A., "A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients", J. Neurol. Neurosurg. Psychiatry, 76, pp.1366~1372 (2005)
22. Heiser, V., "Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay", Proc. Natl. Acad. Sci. U.S.A., 통권 : 99, pp.16400~16406 (2002)
23. Ishiyama, T., "Riluzole slows the progression of neuromuscular dysfunction in the wobbler mouse motor neuron disease", Brain Res., 1019, pp.226~236 (2004)
24. Mortimer, C. G., "Antitumor Benzothiazoles. 26.1 2-(3,4-Dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines", J. Med. Chem., 49, pp.179~185 (2006)
25. Pietrancosta, N., "Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism", J. Med. Chem., 49, pp.3645~3652 (2006)
26. Mathis, C. A., "A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain", Bioorg. Med. Chem. Lett., 12, pp.295~298 (2002)
27. Klunk, W. E., "The binding of 2-(4'-methylaminophenyl) benzothiazole to postmortem brain homogenates is dominated by the amyloid component", J. Neurosci., 23, pp.2086~2092 (2003)
28. Choi, M. M., "Protective effect of benzothiazole derivative KHG21834 on amyloid beta-induced neurotoxicity in PC12 cells and cortical and mesencephalic neurons", Toxicology, 239, pp.156~166 (2007)
29. Kim, E. A., "Suppression of lipopolysaccharide-induced microglial activation by a benzothiazole derivative" (2010), Mol. Cells (in press)
30. Small, D. H., "Alzheimer's disease and Aβ toxicity: from top to bottom", Nat. Rev. Neurosci., 2, pp.595~598 (2001)
31. Sebastiani, G., "The cAMP-specific phosphodiesterase 4B mediates Aβ-induced microglial activation", Neurobiol. Aging, 27, pp.691~701 (2006)
32. White, J. A., "Differential effects of oligomeric and fibrillar amyloid-beta1-42 on astrocyte-mediated inflammation", Neurobiol. Dis., 18, pp.459~465 (2005)
33. Craft, J. M., "Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human β-amyloid in a murine model of neuroinflammation", J. Mol. Neurosci., 24, pp.115~122 (2004)
34. Craft. J. M., "Aminopyridazines inhibit β-amyloid-induced glial activation and neuronal damage in vivo", Neurobiol. Aging, 25, pp.1283~1292 (2004)
35. Craft, J. M., "Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid", J. Neuroinflammation, 2, pp.15~23 (2005)
36. Craft, J. M., "Enhanced susceptibility of S100B transgenic mice to neuroinflammation and neuronal dysfunction induced by intracerebroventricular infusion of human β-amyloid", Glia, 51, pp.209~216 (2005)
37. Akiyama, H., "Inflammation and Alzheimer's disease", Neurobiol. Aging, 21, pp.383~421 (2000)
38. Ranaivo, H. R., "Glia as a therapeutic target: selective suppression of human amyloid-β-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration", J. Neurosci., 26, pp.662~670 (2006)
39. Cheramy, A., "Riluzole inhibits release of glutamate in the caudate nucleus of the cat in vitro", Neurosci. Lett., 147, pp.209~212 (1992)
40. Frautschy, S. A., "Rodent models of Alzheimer’s disease: rat Aβ infusion approaches to amyloid deposits", Neurobiol. Aging, 17, pp.311~321 (1996)
41. Laursen, S. E., "Intracerebroventricular injections in mice. Some methodological refinements", J. Pharmacol. Methods, 16, pp.355~357 (1986)

관련 논문AI추천